Detalles de la búsqueda
1.
Cost-effectiveness analysis for avelumab first-line maintenance treatment of advanced urothelial carcinoma in Scotland.
Future Oncol
; 20(8): 459-470, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37529943
2.
Physician reported treatment patterns and outcomes in metastatic bladder cancer in the USA: the CancerMPact® Survey 2020.
Future Oncol
; 20(10): 613-622, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37357780
3.
Treatment patterns and clinical outcomes in metastatic urothelial carcinoma: a German retrospective real-world analysis.
Future Oncol
; 2024 Apr 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38647011
4.
Treatment patterns in metastatic bladder cancer in Japan: results of the CancerMPact® survey 2020.
Future Oncol
; 20(10): 603-611, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38214131
5.
Undertreatment in patients with advanced urothelial cancer: systematic literature review and meta-analysis.
Future Oncol
; 2023 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37526215
6.
Real-world symptoms, disease burden, resource use and quality of life in US patients with advanced renal cell cancer.
Future Oncol
; 17(17): 2169-2182, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33631973
7.
Real-world outcomes among US Merkel cell carcinoma patients initiating immune checkpoint inhibitors or chemotherapy.
Future Oncol
; 16(31): 2521-2536, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32883109
8.
Treatment patterns, outcomes and clinical characteristics in advanced renal cell carcinoma: a real-world US study.
Future Oncol
; 16(36): 3045-3060, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32885666
9.
Making sense of it: a brief programme to improve reading comprehension in adolescents with language impairments in main stream school.
Int J Lang Commun Disord
; 50(6): 776-87, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25800151
10.
Real-World Analysis of Treatment Patterns and Platinum-Based Treatment Eligibility of Patients With Metastatic Urothelial Cancer in 5 European Countries.
Clin Genitourin Cancer
; 22(1): e136-e147.e1, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37945404
11.
Understanding Clinician Preferences for Treatment Attributes in Oncology: A Discrete Choice Experiment of Oncologists' and Urologists' Preferences for First-Line Treatment of Locally Advanced/Unresectable Metastatic Urothelial Carcinoma in Five European Countries.
Pharmacoeconomics
; 2024 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38472738
12.
Healthcare resource utilization and associated costs in patients with metastatic urothelial carcinoma: a real-world analysis using German claims data.
J Med Econ
; 27(1): 531-542, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38639988
13.
Cost-effectiveness of avelumab first-line maintenance therapy for adult patients with locally advanced or metastatic urothelial carcinoma in France.
PLoS One
; 19(5): e0302548, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38728337
14.
Nationwide Study of Real-World Treatment Patterns and Clinical Outcomes in Patients with Metastatic Urothelial Carcinoma in Hungary.
Adv Ther
; 40(12): 5475-5488, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37831384
15.
Evaluating Real-World Characteristics of Patients With Advanced Urothelial Carcinoma Eligible for Avelumab Maintenance Therapy: A Multicountry Retrospective Medical Chart Review.
Clin Genitourin Cancer
; 21(4): 459-466, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37149458
16.
A cost-effectiveness analysis of avelumab plus best supportive care versus best supportive care alone as first-line maintenance treatment for patients with locally advanced or metastatic urothelial carcinoma in Taiwan.
Cancer Rep (Hoboken)
; 6(10): e1887, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37640556
17.
Treatment Sequencing Patterns in Patients with Metastatic Urothelial Cancer Treated in the Community Practice Setting in the United States: SPEAR-Bladder (Study informing treatment Pathway dEcision in bladder cAnceR).
Clinicoecon Outcomes Res
; 12: 645-656, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33192078
18.
Budget impact model of avelumab in patients with metastatic merkel cell carcinoma in the US.
Clinicoecon Outcomes Res
; 11: 349-359, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31190927
19.
Correction to: Nationwide Study of Real-World Treatment Patterns and Clinical Outcomes in Patients with Metastatic Urothelial Carcinoma in Hungary.
Adv Ther
; 41(2): 881-882, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38070042
20.
Budget Impact Of Including Avelumab As A Second-Line Treatment For Locally Advanced Or Metastatic Urothelial Cancer In The United States: Commercial And Medicare Payer Perspectives.
Clinicoecon Outcomes Res
; 11: 659-672, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31807039